Periodontitis is the utmost common chronic oral disease that exhibits intense susceptibility to aging. Aging is characterized by persistent sterile low-grade
inflammation, leading to age-related periodontal complications represented by
alveolar bone loss. Currently,
forkhead transcription factor O1 (FoxO1) is generally believed to have a significant role in body development, senescence, cell viability, and oxidative stress in numerous organs and cells. However, the role of this
transcription factor in mediating age-related alveolar
bone resorption has not been examined. In this study, FoxO1 deficiency was discovered to have a beneficial correlation with halting the progression of alveolar
bone resorption in aged mice. To further investigate the function of FoxO1 in age-related alveolar
bone resorption, osteoblastic-specific FoxO1 knockout mice were generated, leading to an amelioration in
alveolar bone loss compared to aged-matched wild-type mice, manifested as enhanced osteogenic potential. Mechanistically, we identified enhancement of the NLRP3
inflammasome signaling in FoxO1-deficient osteoblasts in the high dose of
reactive oxygen species. Concordant with our study,
MCC950, a specific inhibitor of NLRP3
inflammasome, greatly rescued osteoblast differentiation under oxidative stress. Our data shed light on the manifestations of FoxO1 depletion in osteoblasts and propose a possible mechanism for the
therapy of age-related
alveolar bone loss.